Methods of ameliorating the effects of alcoholic liver damage
According to embodiments of the present disclosure, a method of treating, preventing or ameliorating acute alcoholic liver damage in a subject comprises administering to the subject an exogenous source of nicotinamide adenine dinucleotide (NAD+) comprising NADH (nicotinamide adenine dinucleotide (NAD)+hydrogen (H)) or NRH (dihydronicotinamide nucleoside). Administration of the exogenous source of NAD+ may also be used to increase a subject's tolerance to alcohol, and/or to treat, prevent or alleviate the symptoms of an alcohol hangover.
1. A method of treating, ameliorating, or reducing the likelihood of developing acute alcoholic liver damage in a subject, the method comprising administering to the subject a composition comprising:
an effective amount of NADH (nicotinamide adenine dinucleotide (NAD)+hydrogen (H)) and/or NRH (dihydronicotinamide nucleoside).
2. The method of claim 1 , wherein the administration of the composition comprises administering the composition prior to the subject consuming or being exposed to alcohol.
3. The method of claim 1 , wherein the administration of the composition comprises administering the composition after the subject has consumed or been exposed to alcohol.
4. The method of claim 1 , wherein the administration of the composition comprises orally administering to the subject a dietary supplement comprising the composition.
5. The method of claim 1 , wherein the administration of the composition comprises orally administering to the subject a pharmaceutical composition comprising the composition.
6. The method of claim 5 , wherein the pharmaceutical composition comprises one or more pharmaceutically acceptable carriers, excipients, adjuvants and/or diluents.
7. The method of claim 1 , wherein the administration of the composition comprises administering a dose of the NADH and/or NRH of about 0.01 mg/kg to about 20 mg/kg per day.
8. The method of claim 4 , wherein the administration of the composition comprises administering a daily dose of the NADH and/or NRH.
9. The method of claim 7 , wherein the administration of the composition comprises administering a daily dose of the NADH and/or NRH for a period of 1 day to 14 days.
10. A method of increasing a subject's tolerance of alcohol, the method comprising administering to the subject a composition comprising:
an effective amount of NADH (nicotinamide adenine dinucleotide (NAD)+hydrogen (H)) and/or NRH (dihydronicotinamide nucleoside).
11. The method of claim 10 , wherein the administration of the composition comprises administering the composition prior to the subject consuming or being exposed to alcohol.
12. The method of claim 10 , wherein the administration of the composition comprises orally administering to the subject a dietary supplement comprising the composition.
13. The method of claim 10 , wherein the administration of the composition comprises administering a dose of the NADH and/or NRH of about 0.01 mg/kg to about 20 mg/kg per day.
14. The method of claim 12 , wherein the administration of the composition comprises administering a daily dose of the NADH and/or NRH.
15. A method of treating, alleviating, or reducing the severity of or the likelihood of developing the symptoms of an alcohol hangover in a subject, the method comprising administering to the subject a composition consisting comprising:
an effective amount of NADH (nicotinamide adenine dinucleotide (NAD)+hydrogen (H)) and/or NRH (dihydronicotinamide nucleoside).
16. The method of claim 15 , wherein the administration of the composition comprises administering the composition prior to the subject consuming or being exposed to alcohol.
17. The method of claim 15 , wherein the administration of the composition comprises administering the composition after the subject has consumed or been exposed to alcohol.
18. The method of claim 15 , wherein the administration of the composition comprises orally administering to the subject a dietary supplement comprising the composition.
19. The method of claim 15 , wherein the administration of the composition comprises administering a dose of the NADH and/or NRH of about 0.01 mg/kg to about 20 mg/kg per day.